Transcriptomics also suggested the involvement of MEKs and ERKs, which are cytoprotective and prooncogenic protein kinases [51–53] that play an active role in the progression of ovarian cancer [10, 54–56]. The gene discussed is WEE1; the disease is ovarian carcinoma.